Lung Cancer Considered

By IASLCScience

Lung Cancer Considered episodes

December 02, 2024 Lung Cancer Considered in German
Lung Cancer Considered in German by IASLC
53 min
November 29, 2024 LALCA Highlights in Spanish
Description: Join us for an engaging discussion on groundbreaking research from investigators across Latin America, featuring insights from large lung cancer screening programs in Mexico and real-world data from the FLAURA-2 study.
Titulo: Únete a nosotros para discutir nuevos datos e interesantes presentados por investigadores emergentes en América Latina, desde grandes programas de detección temprana de cáncer de pulmón en México hasta datos del mundo real de FLAURA-2.
Guest: Dr. Sergio Mejia – Oncologo clínico de la Fundación Instituto de Cancerología en Bogota, Colombia presento Datos del mundo real usando FLAURA-2
Guest: Dr. Luis Leonardo Rojas – Jefe Unidad Funcional GU y Tórax, Fundación CTIC-Luis Carlos Sarmiento Angulo, Bogota Colombia presento sobre el beneficio económico de tener estudios clínicos en Colombia para los canceres mas comunes
Guest: Dra. Marisol Arroyo, pulmonologa del instituto de cancerología en la ciudad de Mexico. Discutió con nosotros los programas de detección temprana para el cancer de pulmón en Mexico
32 min
November 29, 2024 LAURA Trial Part 1
Lung Cancer Considered host Dr. Narjust Florez and Dr. Suresh Ramalingam discuss the recent FDA approval of osimertinib after chemo-radiation in EGFR positive NSCLC. The approval was based, in part, on the results of the LAURA trial, which was presented at the 2024 ASCO Annual Meeting.
Guest: Dr. Suresh Ramalingam is the Executive Director, Winship Cancer Institute of Emory University, the Roberto C. Goizueta Distinguished Chair for Cancer Research, and a professor of medicine at Emory University School of Medicine. He is also the editor in chief for the Cancer Journal.
28 min
November 29, 2024 Ninth Edition of Tumor, Node and Metastasis (TNM) Classification System
In this episode of Lung Cancer Considered, host Dr. Stephen Liu and guests preview the publication of the Ninth Edition of Tumor, Node and Metastasis (TNM) Classification System for lung cancer. The new edition will be published in January 2025 and has some important changes that reflect an evolving understanding of the disease and more rigorous analysis of data from around the world.
Guest: Dr. Valerie Rusch is a Thoracic Surgeon from Memorial Sloan Kettering Cancer CenterMSKCC where she is Vice Chair for Clinical Research in the Department of Surgery and the Miner Family Chair in Intrathoracic Cancers. She has held many leadership positions in the American College of Surgeons and other organizations and was part of the team to first described EGFR mutations. She has been chair of the Thoracic Committee for the American Joint Committee on Cancer 6th, 7th, 8th, and now 9th Editions of the Cancer Staging Handbook
Guest: Dr. Hisao Asamura is a Professor of Surgery, Chief of Division of Thoracic Surgery at Keio University School of Medicine in Tokyo, Japan and Vice President of the Japan Lung Cancer Society. For IASLC, he is the Chair of the Staging and Prognostic Factors Committee, former Executive Board Director, and Congress President for the 18th World Conference on Lung Cancer.
Guest: Dr. Enrico Ruffini is a Thoracic Surgeon and Professor of Thoracic Surgery from the University of Torino, Italy where he is the Chief of the Thoracic Surgery Unit and Director of the Thoracic Surgery Residency Program. He is heavily involved in the European Society of Thoracic Surgeons and Chair of the IASLC Staging and Prognostic Factors Committee – Thymic domain.
36 min
November 26, 2024 Lung Cancer Considered--The Year in Review
Lung cancer breakthroughs, practice updates, and key meetings made 2024 one of the most consequential years in recent memory for lung cancer researchers and clinicians. Lung Cancer Considered hosts Dr. Narjust Florez and Dr. Stephen Liu reviewed important meetings and significant clinical trials from 2024 in this special episode.
46 min
November 13, 2024 LCC in Hindi: Contemporary Issues in Lung Cancer Care
In this episode of Lung Cancer Considered, Dr. Aakash Desai moderates a discussion in Hindi on management of non-small cell lung cancer and small cell lung cancer in the Indian context. The group discusses advances in immunotherapy in resectable NSCLC and other new treatments on the horizon.
Host: Dr. Aakash Desai is an Assistant Professor of Medicine at the O'Neal Comprehensive Cancer Center, University of Alabama in Birmingham, Alabama. He is the Co-Chair, Lung Cancer Working Group, and Associate Director, Phase 1 and Precision Oncology Program.
Guest: Dr. Navneet Singh is a Professor, Department of Pulmonary Medicine, Postgraduate Institute of Medical Education & Research (PGIMER) in Chandigarh, India.
Guest: Dr. Sewanti Limaye is the Director of Medical & Precision Oncology and Director of Clinical and Translational Oncology Research at the Sir HN Reliance Foundation Hospital and Research Centre in Mumbai, India. She is the Co-Chair of the Asia Pacific Coalition Against Lung Cancer.
30 min
November 13, 2024 Virtual Tumor Board_Metastatic Squamous NSCLC
Description: In this virtual tumor board episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the management of a patient with metastatic squamous NSCLC. Listen to the episode to learn how the guests would approach this case.
Guest: Dr. Pilar Garrido is an Associate Professor of Medical Oncology at Universidad de Alcalá in Madrid, Spain, and the Head of the Thoracic Tumours Section at the University Hospital Ramón y Cajal
X: @Piuchagarrido
Guest: Dr. Jared Weiss is a Professor of Medicine and Section Chief of Thoracic and Head & Neck Oncology at the University of North Carolina, Chapel Hill, N.C.
@DrJaredWeiss
43 min
November 12, 2024 Virtual Tumor Board: Pregnancy
Description: As the incidence of lung cancer in those under age 35 increases, oncologists are finding that pregnancy is a central issue for many young women who are coping with lung cancer. In this episode of Lung Cancer Considered, host Dr. Narjust Florez and guests discuss some of the critical issues facing women with lung cancer who are pregnant, or attempting to start a family.
Guest: Dr. Ross Camidge is a Thoracic Medical Oncologist and the Director of the Thoracic Oncology Clinical and Clinical Research Programs at the University of Colorado.
Guest: Dr. Martina Imbimbo is a Thoracic Medical Oncologist at the IOSI Oncology Institute of Southern Switzerland where she specializes in immunooncology and targeted therapy.
48 min
November 05, 2024 IASLC - Exercise And Lung Cancer
The Power of Movement: Exercise and Lung Cancer-- a Conversation with Experts
Description: In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion about the role exercise plays in complementing cancer treatment and how clinicians can work with patients to add regular exercise to their daily regimen.
Guest: Dr. Morten Quist is an associate professor at Copenhagen University and a Physiotherapist Clinician-Researcher with 20 years expertise prescribing exercise for patients with cancer at the University Hospital of Copenhagen (Rigshospitalet). He is the Co-founder of the “Body and Cancer” and Founder of the EXHALE programs.
Guest: Nancy Campbell is a Clinical Exercise Physiologist in the Zakim Center at Dana-Farber Cancer Institute, and she is a Certified ACE Personal Trainer, and has earned the American College of Sports Medicine Cancer Exercise Trainer Certification.
Guest: Dr. Paulo Bergerot is a Medical Oncologist at Oncoclinicas in Brazil, where he specializes in GU malignancies, and focuses on research in the area of exercise and cancer. He has created a remote exercise program for cancer survivors.
55 min
October 29, 2024 IASLC - Hot Topic Meeting On Tolerance And Resistance To Targeted Therapy In NSCLC 2
Title: IASLC Hot Topic Meeting on Tolerance and Resistance to Targeted Therapy in NSCLC (recorded on 10/21)
Description: In this episode of Lung Cancer Considered, host Dr. Stephen Liu previews the upcoming IASLC Hot Topic Meeting on Tolerance and Resistance to Targeted Therapy in NSCLC. To discuss this exciting new meeting and this topic, he is joined by the four co-chairs of the meeting. To learn more about the meeting, visit https://www.httr2024-iaslc.org/.
Guest: Dr. Alice Berger is an Associate Professor in the Human Biology Division and the Herbold Computational Biology Program at the Fred Hutchinson Cancer Center at the University of Washington in Seattle, Wash.
X: @aliceb_phd
Guest: Dr. Kenichi Suda, Associate Professor in the Division of Thoracic Surgery at Kindai University School of Medicine in Osaka, Japan.
X: NA
Guest: Dr. Montse Sanchez-Cespedes is the Group Leader at the Josep Carreras Research Institute, in Badalona, Spain
X: @CespedesMontse
Guest: Dr. William Lockwood, Senior Scientist in Integrative Oncology at the BC Cancer Research Institute and Associate Professor in Pathology & Laboratory Medicine at the University of British Columbia in Vancouver, Canada
X: @WWL_18
24 min

About Lung Cancer Considered

From the publisher's feed

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.